Remove Competition Remove Networking Remove Pharmaceutical manufacturing Remove White Paper
article thumbnail

What factors are driving life sciences FDI in 2022?

Pharmaceutical Technology

Locating a subsidiary in close proximity to such an institution has advantages beyond pipeline talent, as there is the potential to access research and tap into networks for product development and clinical trials. Download the white paper ‘Charleston, USA: A life sciences hub’ here. Industry clusters.

article thumbnail

‘Right shoring’ API production in Europe

Pharmaceutical Technology

This will enable them to expand their clinical trial supplies and logistics offerings, and expand networks for on-time delivery of supplies and drugs. Moreover, US Pharmacopeia issued the first-ever Medicine Supply Map to find and quantify risks in upstream pharmaceutical supply chains across the country.

article thumbnail

Using big data to stabilise pharma supply chains in an age of disruption

Pharmaceutical Technology

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised.

Pharma 52